Mold IllnessNCT07605078
Associations Between Household Mold Levels and Physical and Mental Health: A Mold and Mycotoxin Testing Research Registry
An observational study of Mold Illness and Mold or Dust Allergy, run by OvationLab at 1 site in United States.
Trial summary
The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Mold Illness, Mold or Dust Allergy
- What is being tested?
- Mold-specific quantitative PCR (MSQPCR) testing
- How many people
- 2,500 participants
- Where
- 1 siteUnited States
- Study dates
- 27 Apr 2026to Apr 2029
- How long will I take part?
- 5 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.
Who may be able to join
- All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.
Who cannot join
- Dust Test users who do not provide informed consent for deidentified analysis and peer-reviewed publication of their data.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
OvationLab
Richmond, Virginia, 23220
Study Administration, (240) 232-2103
About this study
The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. In addition, associations between mold exposures and mycotoxin levels among users who have done mycotoxin lab testing will also be evaluated.
- Conditions
- Mold Illness, Mold or Dust Allergy
- Being tested
- Mold-specific quantitative PCR (MSQPCR) testing
- Keywords
- Mold
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mold-specific quantitative PCR (MSQPCR) testingOther
The Dust Test is mold-specific quantitative PCR (MSQPCR) analysis that is being utilized to evaluate the associations between household mold organisms and a variety of human health outcomes.
What is being measured
The primary outcome is the main question the study is designed to answer.
PROMIS - Global Health
Ten questions assessing physical and mental health. Higher scores indicate superior physical and mental health.
Measured: Assessed at the time that the mold test is collected (cross-sectional)
Secondary outcomes (2)
Mold-related symptoms
A set of 41 potentially mold-related symptoms. Higher scores indicated worse symptoms.
Measured: Assessed at the time that the mold test is collected (cross-sectional)
Mycotoxin levels
Urinary mycotoxin levels will be assessed. Higher levels indicated greater mycotoxin presence.
Measured: Assessed at the time that the mold test is collected (cross-sectional)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 May 2026
- Study start27 Apr 2026
- Primary completionApr 2029 (estimated)
- Study completionApr 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mold IllnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 2,500 participants (estimated)
- Target duration
- 5 Years
Sponsor and investigators
- Lead sponsor
- OvationLab
- Sponsor type
- Research network
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07605078
- Sponsor's protocol ID
- TDT - 001
- Status last verified
- May 2026
- First submitted
- 18 May 2026
- Last updated
- 7 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Mold results and participant-reported outcomes
Study at a glance
From the registry record, last updated by the sponsor on 7 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Associations Between Household Mold Levels and Physical and Mental Health: A Mold and Mycotoxin Testing Research Registry
- ClinicalTrials.gov ID
- NCT07605078
- Acronym / sponsor ID
- TDT - 001
- Conditions
- Mold Illness, Mold or Dust Allergy
- Keywords
- Mold
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 2,500 participants (estimated)
- Lead sponsor
- OvationLabResearch network
- Study start
- 27 Apr 2026 (actual)
- Primary completion
- Apr 2029 (estimated)
- Study completion
- Apr 2029 (estimated)
- First posted
- 22 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary purpose of this study is to evaluate cross-sectional associations between mold exposures identified with The Dust Test and self-reported physical health, emotional health, and medical diagnoses. In addition, associations between mold exposures and mycotoxin levels among users who have done mycotoxin lab testing will also be evaluated.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 5 Years
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.
Key inclusion criteria (1 listed)
- All Dust Test users who provide informed consent for deidentified analysis and peer-reviewed publication of their data will be eligible to participate in the research registry.
Key exclusion criteria (1 listed)
- Dust Test users who do not provide informed consent for deidentified analysis and peer-reviewed publication of their data.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mold-specific quantitative PCR (MSQPCR) testingThe Dust Test is mold-specific quantitative PCR (MSQPCR) analysis that is being utilized to evaluate the associations between household mold organisms and a variety of human health outcomes. | Other | – |
Primary outcome
PROMIS - Global Health
Time frame: Assessed at the time that the mold test is collected (cross-sectional)
Ten questions assessing physical and mental health. Higher scores indicate superior physical and mental health.
2 secondary outcomes
Mold-related symptoms
Time frame: Assessed at the time that the mold test is collected (cross-sectional)
Mycotoxin levels
Time frame: Assessed at the time that the mold test is collected (cross-sectional)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jul 2026.
- Individual participant dataSharing planned: Yes. Mold results and participant-reported outcomes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Mold Illness and Mold or Dust Allergy, run by OvationLab at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Study Administrator ((240) 232-2103, info@ovationlab.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
PROMIS - Global Health (time frame: Assessed at the time that the mold test is collected (cross-sectional)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.